Literature DB >> 514931

Propranolol in acute intermittent porphyria.

A S Menawat, R B Panwar, D K Kochar, C K Joshi.   

Abstract

Twenty cases of acute intermittent porphyria were studied during the acute phase. Cardiovascular manifestations were noted in all the cases, with tachycardia in 20 and with hypertension in 17. Propranolol in doses ranging from 20--200 mg was given to all the cases and produced adequate control of tachycardia and hypertension. At follow-up, smaller doses of propranolol were found to maintain the pulse rate and BP within normal limits and also to prevent acute attacks.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 514931      PMCID: PMC2428078          DOI: 10.1136/pgmj.55.646.546

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  3 in total

1.  The neuropathology of acute porphyria.

Authors:  J B GIBSON; A GOLDBERG
Journal:  J Pathol Bacteriol       Date:  1956-04

2.  Letter: Hazard of propranolol in treatment of acute prophyria.

Authors:  H L Bonkowsky; D P Tschudy
Journal:  Br Med J       Date:  1974-10-05

3.  Acute intermittent porphyria: response of tachycardia and hypertension to propranolol.

Authors:  A D Beattie; M R Moore; A Goldberg; R L Ward
Journal:  Br Med J       Date:  1973-08-04
  3 in total
  1 in total

Review 1.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.